Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Gene Therapy00:59

Gene Therapy

28.1K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
28.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Severe Hypoprothrombinemia Associated With Vitamin K Deficiency During Prolonged Cefazolin Therapy in a Hemodialysis Patient.

Cureus·2026
Same author

Spectroscopic Analysis of the Extracellular Matrix Hierarchical Structure in Naked Mole-Rat Skin.

Gels (Basel, Switzerland)·2026
Same author

Analgesic use and changes in renal function in patients with heart failure in a real-world setting: a descriptive study using an electronic medical record database.

American heart journal plus : cardiology research and practice·2026
Same author

Ketone Body Supplementation Exerts Renoprotective Effects Against Adenine-Induced Kidney Injury via OXCT1-Mediated Ketolysis in Mice.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology·2026
Same author

Repeated low-dose streptozotocin induces latent renal proximal tubular injury independently of blood glucose.

Molecular and cellular endocrinology·2026
Same author

Monocytes Provoke Breast Cancer Cells to Express PD-L1 via a Cell-to-Cell Interaction Involving CD44 and Moesin.

Journal of immunotherapy (Hagerstown, Md. : 1997)·2026

Related Experiment Video

Updated: Apr 1, 2026

Hydrodynamic Renal Pelvis Injection for Non-viral Expression of Proteins in the Kidney
08:26

Hydrodynamic Renal Pelvis Injection for Non-viral Expression of Proteins in the Kidney

Published on: January 8, 2018

19.8K

Kidney-specific Sonoporation-mediated Gene Transfer.

Ryo Ishida1, Daisuke Kami2, Tetsuro Kusaba1

  • 1Division of Nephrology, Department of Internal Medicine, Graduate School of Medical Science Kyoto Prefectural University of Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japan.

Molecular Therapy : the Journal of the American Society of Gene Therapy
|October 1, 2015
PubMed
Summary

Local kidney sonoporation enables efficient delivery of systemically administered oligonucleotides to tubular epithelium. This technique shows promise for treating ischemic acute kidney injury by reducing tumor necrosis factor alpha expression.

More Related Videos

Direct Drug Delivery to Kidney via the Renal Artery
11:18

Direct Drug Delivery to Kidney via the Renal Artery

Published on: April 17, 2021

8.5K
Delivery of Exogenous Artificially Synthesized miRNA Mimic to the Kidney Using Polyethylenimine Nanoparticles in Several Kidney Disease Mouse Models
07:01

Delivery of Exogenous Artificially Synthesized miRNA Mimic to the Kidney Using Polyethylenimine Nanoparticles in Several Kidney Disease Mouse Models

Published on: May 10, 2022

2.0K

Related Experiment Videos

Last Updated: Apr 1, 2026

Hydrodynamic Renal Pelvis Injection for Non-viral Expression of Proteins in the Kidney
08:26

Hydrodynamic Renal Pelvis Injection for Non-viral Expression of Proteins in the Kidney

Published on: January 8, 2018

19.8K
Direct Drug Delivery to Kidney via the Renal Artery
11:18

Direct Drug Delivery to Kidney via the Renal Artery

Published on: April 17, 2021

8.5K
Delivery of Exogenous Artificially Synthesized miRNA Mimic to the Kidney Using Polyethylenimine Nanoparticles in Several Kidney Disease Mouse Models
07:01

Delivery of Exogenous Artificially Synthesized miRNA Mimic to the Kidney Using Polyethylenimine Nanoparticles in Several Kidney Disease Mouse Models

Published on: May 10, 2022

2.0K

Area of Science:

  • Biomedical Engineering
  • Nephrology
  • Molecular Therapy

Background:

  • Sonoporation facilitates targeted agent delivery to organs via systemic administration, minimizing adverse effects.
  • Previous applications of sonoporation have involved diverse materials and organs.
  • Tumor necrosis factor alpha (TNFα) is a key mediator in renal ischemia-reperfusion injury.

Purpose of the Study:

  • To demonstrate efficient oligonucleotide transfer to the kidney's tubular epithelium using local sonoporation.
  • To investigate the potential of renal sonoporation for treating ischemic acute kidney injury.
  • To assess the efficacy of targeting TNFα with small interfering RNA (siRNA) in a murine model.

Main Methods:

  • Local sonoporation applied to the kidney.
  • Systemic administration of oligonucleotides.
  • Ultrasonic wave irradiation to induce microbubble collapse and transiently alter glomerular permeability.
  • Targeting TNFα using siRNA in a murine model of renal ischemia-reperfusion injury.

Main Results:

  • Highly efficient and specific transfer of systemically administered oligonucleotides to the tubular epithelium was achieved.
  • Ultrasonic wave irradiation transiently increased glomerular permeability, allowing oligonucleotide passage.
  • Reduction in TNFα expression via single gene transfer significantly inhibited kidney injury markers.

Conclusions:

  • Local sonoporation to the kidney offers a highly efficient method for delivering systemically administered oligonucleotides to tubular epithelial cells.
  • This approach holds potential for clinical applications in treating ischemic acute kidney injury.
  • Systemic siRNA administration combined with temporary, local sonoporation is a promising strategy for gene therapy in kidney injury.